about
New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromesEstimating summary measures of health: a structured workbook approach.Rheumatoid arthritis and periodontal diseaseHigh-Grade Salivary-Gland Involvement, Assessed by Histology or Ultrasonography, Is Associated with a Poor Response to a Single Rituximab Course in Primary Sjögren's Syndrome: Data from the TEARS Randomized Trial.Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy.Cervical cancer mortality by neighbourhood income in urban Canada from 1971 to 1996.The placebo effect in rheumatology: new data.Regulatory B cells play a key role in immune system balance.IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry.Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control study.Sinus aspergilloma in rheumatoid arthritis before or during tumor necrosis factor-alpha antagonist therapyA combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis.New pathogenic hypotheses for spondyloarthropathies.Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome?Role for suppressor T cells in the pathogenesis of autoimmune diseases (including rheumatoid arthritis). Facts and hypotheses.Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic Trial.Suspected disk space infection with negative microbiological tests-report of eight cases and comparison with documented pyogenic discitis.Provocative sacroiliac joint maneuvers and sacroiliac joint block are unreliable for diagnosing sacroiliac joint pain.B-cell and T-cell quantification in minor salivary glands in primary Sjögren's syndrome: development and validation of a pixel-based digital procedureCurrent management of reflex sympathetic dystrophy syndrome (complex regional pain syndrome type I).Clinical practice format for choosing a second-line disease modifying anti-rheumatic drug in early rheumatoid arthritis after failure of 6 months' first-line DMARD therapy.Contribution of centralization phenomenon to the diagnosis, prognosis, and treatment of diskogenic low back pain.Determinants of unacceptable waiting times for specialized services in Canada.Thymic Hassall's corpuscles, regulatory T-cells, and rheumatoid arthritis.Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literature.Cystic angiomatosis, a heterogeneous condition: Four new cases and a literature review.Role for interleukin-6 in structural joint damage and systemic bone loss in rheumatoid arthritis.Information on glucocorticoid therapy in the main studies of biological agents.Safety and efficacy of anti-tumor necrosis factor α therapy in ten patients with recent-onset refractory reactive arthritis.TNF alpha antagonist therapy and safety monitoring.Abatacept therapy and safety management.Side effects of corticosteroid injections: what's new?Evidence supporting a role for dormant bacteria in the pathogenesis of spondylarthritis.Osteoclasts in RA: diverse origins and functions.Pathogenesis of hyperostosis: a key role for mesenchymatous cells?Essential role for CD103+ cells in the pathogenesis of spondyloarthritides.Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug: A Randomized Clinical Trial.Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: results of the multicentre non-inferiority randomised open-label controlled trial (STRASS: Spacing of TNF-blocker injections in Rheumatoid ArthriStrong opioids for noncancer pain due to musculoskeletal diseases: Not more effective than acetaminophen or NSAIDs.Rampant infections of bone marrow stem cell niches as triggers for spondyloarthropathies and rheumatoid arthritis.
P50
Q24613164-C709863D-AEFD-4C24-8F18-25E29C47DA1CQ24811513-F811D29A-3D4D-4F41-9C0B-5D04AB23B358Q29394246-14BA628C-2486-44D3-9937-47D1ABEC3137Q30372606-5B2A9BB2-50C0-49B0-9BC5-ABA9BA1FBA7AQ30948155-08583299-8956-4037-84C8-0A1635FCB6E7Q33554969-E41214B3-E6BF-478C-BB26-BCFF7ACBF7D1Q33695408-78B2884E-D9C4-4AD5-A3A6-F06BF4F51C97Q34033040-58506007-5D23-4C56-8118-55F2BC23A231Q34111902-F9C334FC-A03F-40B7-A00F-9F5659B3C7E4Q34153015-8342C597-773F-460B-9F81-80B3E0538086Q34413227-2FF04767-398E-42D1-B64B-08D04AB17F08Q34413330-22598FC3-6BD6-47EC-8EEE-520AFDB90D59Q34654525-9E3C1E94-3F0A-4E96-8200-B90173C10EA0Q35774612-4B8B6006-97A1-4F02-927B-5B1D5A31E0C8Q35913220-B15F79B5-06D6-4F3F-9A9B-CEDD09D26027Q36070691-CBB12D5A-AF6C-4C4E-B77D-052AADEF8A9EQ36083499-88237D6A-A28F-4F1F-805C-4C0BE5DF8164Q36388300-DC038DE5-641C-4E14-B322-6CC6729926EFQ36481706-15F3995A-039F-42A4-B18E-98472C1A40A9Q36534505-B63F98F3-009D-47DE-B173-532FEBF972E6Q36694682-F06B1E18-52C2-402B-8554-C24207A3789DQ36850435-6580DD68-2F2E-4E54-BA14-AB13F00B3FB9Q36978758-C74A82F4-8BA8-4783-8477-3F69E7CEF548Q37313628-6F4A6942-9114-409A-8394-68BF9EBCB744Q37342365-57D657D4-5C36-495B-AE11-6B4AA21728E0Q37384171-CB34F5D8-FDFF-48CC-9F0A-ED7BAB51190EQ37742906-9C4B20C5-9119-410B-A95F-8DF3A7297E0DQ37844954-59B9AA46-8A58-43D1-BE35-896E1889E5F8Q37850935-9D713EB0-990B-4046-8D7B-CB0C0DC7B6CAQ37894193-10928F8C-3E16-4ABF-838A-6F1F78777C38Q38006176-D131C64E-E210-48E6-BBBF-A3797D5205ACQ38076943-C3367F9C-AB8E-4FA6-A065-AFAFAD51A73EQ38087740-DC0094C0-D68E-4F2A-9FE3-01DD25575C5FQ38111507-6DCF3996-FC94-4D04-B97A-EDDCD8BCD75DQ38111509-0330C064-771A-4D21-9002-6349452BF2D5Q38252920-C9901B75-D8F9-4183-A180-5EB8AF5727BAQ38387307-7672632E-A75D-43D9-913E-B52B66C0E00CQ38409321-A84088CB-6F0A-47FB-8E41-EBF895CAECEDQ38603343-B1FC336E-E969-4518-B71C-FAE0032E2BB9Q38737466-B82A10FB-B3DA-4F06-80D1-5A13B4241644
P50
name
Jean-Marie Berthelot
@ast
Jean-Marie Berthelot
@en
Jean-Marie Berthelot
@nl
type
label
Jean-Marie Berthelot
@ast
Jean-Marie Berthelot
@en
Jean-Marie Berthelot
@nl
prefLabel
Jean-Marie Berthelot
@ast
Jean-Marie Berthelot
@en
Jean-Marie Berthelot
@nl